Clinical trial

Safety and Efficacy of PolyHeme(R) in Hemorrhagic Shock Following Traumatic…

NCT00076648 · Northfield Laboratories, Industry · Unknown status

Key facts

NCT number NCT00076648
Title Safety and Efficacy of PolyHeme(R) in Hemorrhagic Shock Following Traumatic Injuries Beginning in the Pre-Hospital Setting
Official title A Phase III, Randomized, Controlled, Open-Label, Multicenter, Parallel Group Study Using Provisions for Exception From Informed Consent Requirements Designed to Evaluate the Safety and Efficacy of Poly SFH-P Injection [Polymerized Human Hemoglobin (Pyridoxylated), PolyHeme(R)] When Used to Treat…
Lead sponsor Northfield Laboratories, Industry
Status Unknown status
Phase Phase 3
Study type Interventional
Conditions Hemorrhagic Shock
Intervention type Drug
Interventions Poly SFH-P Injection
First posted Jan 30, 2004
Last update posted Aug 2, 2006
Countries United States

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies